For the year ending 2025-12-31, VYCO made $1,863,400 in revenue. -$396,796 in net income. Net profit margin of -21.29%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 1,863,400 | |||
| Cost of goods sold | 302,293 | |||
| Gross profit | 1,561,107 | |||
| Research and development | 9,963 | |||
| Depreciation and amortization | 59,521 | |||
| Selling, general and administrative | 1,457,723 | |||
| Total operating expenses | 1,527,207 | |||
| Operating income (loss) | 33,900 | |||
| Other income | 0 | |||
| Interest expense | 50,283 | |||
| Loss on foreign currency exchange | -508 | |||
| Total other (expense) income | -104,090 | |||
| Loss before provision for income taxes | -70,190 | |||
| Provision for income taxes | 0 | |||
| Net loss from continuing operations | -70,190 | |||
| Loss from discontinued operations, net of tax | -2,236 | |||
| Net loss | -72,426 | |||
| Preferred stock dividends | 324,370 | |||
| Net loss available to common stockholders | -396,796 | |||
| Basic EPS | -0.01 | |||
| Diluted EPS | -0.01 | |||
| Basic Average Shares | 33,372,796 | |||
| Diluted Average Shares | 33,372,796 | |||
VYCOR MEDICAL INC (VYCO)
VYCOR MEDICAL INC (VYCO)